These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16306604)

  • 21. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
    Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
    J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry.
    Rothwangl KB; Rong L
    Virol J; 2009 Jan; 6():12. PubMed ID: 19171049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein.
    Vieyres G; Dubuisson J; Patel AH
    J Gen Virol; 2011 Mar; 92(Pt 3):494-506. PubMed ID: 21084495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
    Basu A; Beyene A; Meyer K; Ray R
    J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
    Prentoe J; Jensen TB; Meuleman P; Serre SB; Scheel TK; Leroux-Roels G; Gottwein JM; Bukh J
    J Virol; 2011 Mar; 85(5):2224-34. PubMed ID: 21123377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
    Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
    Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.
    Zuiani A; Chen K; Schwarz MC; White JP; Luca VC; Fremont DH; Wang D; Evans MJ; Diamond MS
    J Virol; 2016 Dec; 90(23):10499-10512. PubMed ID: 27630236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV envelope protein function is dependent on the peptides preceding the glycoproteins.
    Bian T; Zhou Y; Bi S; Tan W; Wang Y
    Biochem Biophys Res Commun; 2009 Jan; 378(1):118-22. PubMed ID: 19013428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
    Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients.
    Hino K; Korenaga M; Orito E; Katoh Y; Yamaguchi Y; Ren F; Kitase A; Satoh Y; Fujiwara D; Okita K
    J Viral Hepat; 2002 May; 9(3):194-201. PubMed ID: 12010507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE; Boo I; Maerz AL; Poumbourios P
    J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.
    Goffard A; Callens N; Bartosch B; Wychowski C; Cosset FL; Montpellier C; Dubuisson J
    J Virol; 2005 Jul; 79(13):8400-9. PubMed ID: 15956584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of neutralization antibodie induced by DNA vaccine of HCV envelope protein 2 in mice].
    Shao S; Zhou H; Tong Y; Ren Y; Chen Z
    Wei Sheng Yan Jiu; 2011 May; 40(3):295-8. PubMed ID: 21695897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.
    Boo I; teWierik K; Douam F; Lavillette D; Poumbourios P; Drummer HE
    Biochem J; 2012 Apr; 443(1):85-94. PubMed ID: 22240035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
    Scarselli E; Ansuini H; Cerino R; Roccasecca RM; Acali S; Filocamo G; Traboni C; Nicosia A; Cortese R; Vitelli A
    EMBO J; 2002 Oct; 21(19):5017-25. PubMed ID: 12356718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
    Russell RS; Kawaguchi K; Meunier JC; Takikawa S; Faulk K; Bukh J; Purcell RH; Emerson SU
    J Viral Hepat; 2009 Sep; 16(9):621-32. PubMed ID: 19302336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.